» Articles » PMID: 21097478

Use of an Implantable Loop Recorder to Increase the Diagnostic Yield in Unexplained Syncope: Results from the PICTURE Registry

Abstract

Aims: To collect information on the use of the Reveal implantable loop recorder (ILR) in the patient care pathway and to investigate its effectiveness in the diagnosis of unexplained recurrent syncope in everyday clinical practice.

Methods And Results: Prospective, multicentre, observational study conducted in 2006-2009 in 10 European countries and Israel. Eligible patients had recurrent unexplained syncope or pre-syncope. Subjects received a Reveal Plus, DX or XT. Follow up was until the first recurrence of a syncopal event leading to a diagnosis or for ≥1 year. In the course of the study, patients were evaluated by an average of three different specialists for management of their syncope and underwent a median of 13 tests (range 9-20). Significant physical trauma had been experienced in association with a syncopal episode by 36% of patients. Average follow-up time after ILR implant was 10±6 months. Follow-up visit data were available for 570 subjects. The percentages of patients with recurrence of syncope were 19, 26, and 36% after 3, 6, and 12 months, respectively. Of 218 events within the study, ILR-guided diagnosis was obtained in 170 cases (78%), of which 128 (75%) were cardiac.

Conclusion: A large number of diagnostic tests were undertaken in patients with unexplained syncope without providing conclusive data. In contrast, the ILR revealed or contributed to establishing the mechanism of syncope in the vast majority of patients. The findings support the recommendation in current guidelines that an ILR should be implanted early rather than late in the evaluation of unexplained syncope.

Citing Articles

The Diagnostic Yield of Implantable Loop Recorders Stratified by Indication: A "Real-World" Single-Center Experience.

Pistelli L, Cori A, Parollo M, Torre M, Fiorentini F, Barletta V J Clin Med. 2025; 14(4).

PMID: 40004583 PMC: 11856419. DOI: 10.3390/jcm14041052.


Asymptomatic Brugada syndrome: Navigating implantable cardioverter-defibrillator implantation dilemma.

Lima M, Almeida A, Matos D, Cavaco D, Adragao P HeartRhythm Case Rep. 2025; 10(12):941-945.

PMID: 39897681 PMC: 11781890. DOI: 10.1016/j.hrcr.2024.09.008.


Long-term Monitoring to Detect Risk of Sudden Cardiac Death in Inherited Arrhythmia Patients.

Domain G, Steinberg C, Davies B, Strube C, Roberts J, Simpson C CJC Open. 2024; 6(9):1066-1074.

PMID: 39525816 PMC: 11544277. DOI: 10.1016/j.cjco.2024.05.007.


JCS/JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia.

Takase B, Ikeda T, Shimizu W, Abe H, Aiba T, Chinushi M J Arrhythm. 2024; 40(4):655-752.

PMID: 39139890 PMC: 11317726. DOI: 10.1002/joa3.13052.


Impact of an expanded reimbursement policy on utilization of implantable loop recorders in patients with cryptogenic stroke in Korea.

Gwag H, Ko N, Jin M Korean J Intern Med. 2024; 39(3):469-476.

PMID: 38632895 PMC: 11076896. DOI: 10.3904/kjim.2023.479.


References
1.
Serletis A, Rose S, Sheldon A, Sheldon R . Vasovagal syncope in medical students and their first-degree relatives. Eur Heart J. 2006; 27(16):1965-70. DOI: 10.1093/eurheartj/ehl147. View

2.
Brignole M, Ungar A, Bartoletti A, Ponassi I, Lagi A, Mussi C . Standardized-care pathway vs. usual management of syncope patients presenting as emergencies at general hospitals. Europace. 2006; 8(8):644-50. DOI: 10.1093/europace/eul071. View

3.
Krahn A, Klein G, Norris C, Yee R . The etiology of syncope in patients with negative tilt table and electrophysiological testing. Circulation. 1995; 92(7):1819-24. DOI: 10.1161/01.cir.92.7.1819. View

4.
Linzer M, Pontinen M, Gold D, Divine G, Felder A, Brooks W . Impairment of physical and psychosocial function in recurrent syncope. J Clin Epidemiol. 1991; 44(10):1037-43. DOI: 10.1016/0895-4356(91)90005-t. View

5.
Brignole M, Sutton R, Menozzi C, Garcia-Civera R, Moya A, Wieling W . Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. Eur Heart J. 2006; 27(9):1085-92. DOI: 10.1093/eurheartj/ehi842. View